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ND1 subunityl)phenyldiazirinyl acetogenin, [125I]TDA, a photoafﬁnity labeling probe of
acetogenin, photo-cross-links to the ND1 subunit of bovine heart mitochondrial NADH–ubiquinone
oxidoreductase (complex I) with high speciﬁcity [M. Murai, A. Ishihara, T. Nishioka, T. Yagi, and H. Miyoshi,
(2007) The ND1 subunit constructs the inhibitor binding domain in bovine heart mitochondrial complex I,
Biochemistry 46 6409–6416.]. To identify the binding site of [125I]TDA in theND1 subunit,we carried out limited
proteolysis of the subunit cross-linked by [125I]TDA using various proteases and carefully analyzed the
fragmentation patterns. Our results revealed that the cross-linked residue is locatedwithin the region of the 4th
to 5th transmembrane helices (Val144–Glu192) of the subunit. It is worth noting that an excess amount of short-
chain ubiquinones such as ubiquinone-2 (Q2) and 2-azido-Q2 suppressed the cross-linking by [125I]TDA in a
concentration-dependent way. Although the question of whether the binding sites for ubiquinone and different
inhibitors in complex I are identical remains to be answered, the present study provided, for the ﬁrst time, direct
evidence that an inhibitor (acetogenin) and ubiquinone competitively bind to the enzyme. Considering the
present results along with earlier photoafﬁnity labeling studies, we propose that not all inhibitors acting at the
terminal electron transfer step of complex I necessarily bind to the ubiquinone binding site itself.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionThe NADH–ubiquinone oxidoreductase (complex I) resided in the
respiratory chain is a large membrane protein complex that catalyzes
electron transfer fromNADH to ubiquinone and pumps protons across
the inner mitochondrial or bacterial plasma membrane [1,2]. Electron
microscopy revealed that complex I is L-shaped [3–10] and composed
of a hydrophobic arm embedded in the membrane and a peripheral
arm protruding into the mitochondrial matrix or the bacterial cytosol.
The peripheral arm contains all known redox centers, one FMN and
eight or nine iron–sulfur clusters. Recently, the crystal structure of the
peripheral arm of complex I from Thermus thermophiluswas solved at
a resolution of 3.3 Å [11], revealing the subunit arrangement and the
putative electron transfer pathway. However, our knowledge about
the functional and structural features of the membrane arm, such as
the ubiquinone redox reaction, proton translocation mechanism, and
mode of action of numerous speciﬁc inhibitors, is still highly limited
[1,2,12].
Acetogenins, natural products isolated from the plant family
Annonaceae, are among the most potent inhibitors of bovine heart
mitochondrial complex I [13–16]. There is little structural similarity
between acetogenins and ordinary complex I inhibitors such as81 75 753 6408.
shi).
ll rights reserved.piericidin A, rotenone, and several synthetic agrochemicals like
fenpyroximate, yet acetogenins act at the terminal electron transfer
step of complex I [13,15]. We recently synthesized a photolabile
acetogenin derivative {125I-labeled (triﬂuoromethyl)phenyldiazirinyl
acetogenin, [125I]TDA} as a photoafﬁnity labeling probe (Fig. 1). In this
probe, as the photolabile phenyldiazirine ring works as a mimic of the
γ-lactone ring, one of the two pharmacophores of acetogenins, as well
as a photoreactive group [17], the inhibitory effects of TDAwith bovine
complex I, such as production of superoxide and blockage of the
reverse electron transfer in the enzyme, are comparable to those of
natural acetogenins. A photoafﬁnity labeling study with [125I]TDA
using bovine SMP revealed that this inhibitor cross-links to the ND1
subunit of complex I with high speciﬁcity [17]. The cross-linking of the
ND1 subunit was suppressed by many other traditional inhibitors,
such as rotenone, piericidin A, and fenpyroximate, in a concentration-
dependent manner [17], supporting the concept that a wide variety of
complex I inhibitors bind to distinct, but overlapping regions within a
common inhibitor binding domain [15]. Several lines of experimental
evidence indicate the functional importance of the ND1 subunit
[1,2,18–20], however, the very hydrophobic nature of this protein has
hampered detailed protein chemical analyses [21,22]. Thus, consider-
ing the unusual structural characteristics as well as the very strong
inhibitory effect of acetogenins, further exploration of the inhibition
manner of acetogenins including identiﬁcation of the binding site
would provide valuable insights into the terminal electron transfer
step of complex I.
Fig. 1. Structures of photoafﬁnity probe [125I]TDA and 2-azido-ubiquinone-2.
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here carried out limited proteolysis of the ND1 subunit cross-linked by
[125I]TDA using various proteases and carefully analyzed the frag-
mentation patterns. Our results revealed that the cross-linked residue
is locatedwithin the region of the 4th to 5th transmembrane helices of
the subunit. It is worth noting that the cross-linking by [125I]TDA was
suppressed by an excess amount of short-chain ubiquinones like
ubiquinone-2 (Q2). The present study provided, for the ﬁrst time,
direct evidence that an inhibitor (acetogenin) and ubiquinone
competitively bind to the enzyme.
2. Materials and methods
2.1. Materials
[125I]TDA was synthesized by the procedures reported previously
[17]. 2-Azido-6-geranyl-3-methoxy-5-methyl-1,4-benzoquinone
(2-azido-Q2, Fig. 1) is the same sample as used previously [23].
2.2. Preparation of bovine submitochondrial particles and enzyme assays
Mitochondria were isolated from bovine heart [24]. Submitochon-
drial particles (SMP) were prepared by the method of Matsuno-Yagi
and Hateﬁ [25] using a sonication medium containing 250 mM
sucrose, 1 mM succinate, 1.5 mM ATP,10 mMMgCl2, 10 mMMnCl2 and
10 mM Tris/HCl (pH 7.4), and stored in a buffer containing 250 mM
sucrose and 10mMTris/HCl (pH 7.4) at−80 °C until use. NADHoxidase
activity in SMP was measured spectrometrically with a Shimadzu UV-
3000 (340 nm, ɛ=6.2 mM−1cm−1) at 30 °C.
2.3. Photoafﬁnity labeling of the ND1 subunit in SMP by [125I]AzQ
Bovine SMP (0.3–1.0 mg of protein/mL, 100 μL in a 1.5 mL tube)
were incubated with [125I]AzQ (3–10 nM) in a buffer containing
250 mM sucrose, 1 mM MgCl2 and 50 mM KPi (pH 7.4) for 10 min at
room temperature. Then, the samples were irradiated for 10 min with
a long wavelength UV lamp (Black Ray model B-100A, UVP, Upland,
CA) on ice at a distance of 15 cm from the light source. When
competition was examined, a competitor (short-chain ubiquinone)
was added and incubated for 10 min at room temperature prior to the
treatment with [125I]AzQ.
The photo-cross-linking reaction was quenched by adding 4×
Laemmli's sample buffer as described previously [17], and the samples
were separated by SDS-PAGE [26] on 12.5% Laemmli's gel. After
electrophoresis, the gels were stained with Coomassie brilliant blue(CBB) R-250, dried, and exposed to an Imaging Plate (BAS-MS2040,
Fuji Film, Tokyo, Japan). The migration pattern of the labeled proteins
was visualized with a Bio-Imaging Analyzer FLA-5100 (Fuji Film), and
the incorporated radioactivity into the ND1 was quantiﬁed using
“Multi Gauge” software (Fuji Film).
2.4. Isolation and limited proteolysis of the ND1 subunit cross-linked
by [125I]TDA
For limited proteolysis of the ND1 subunit, [125I]TDA-labeled SMP
were partially isolated by SDS-PAGE on 12.5% Laemmli's gel. The
radioactive area at around 30 kDa was excised and subjected to
electroelution using a Centrilutor with Centricon YM-10 (Millipore,
Billerica, MA) in an elution buffer containing 10 mM Tris/HCl (pH 8.0)
and 0.025% SDS (w/v). Typically, more than 90% of the radioactivity
was recovered from the gel. After exchanging the elution buffer with
the appropriate digestion buffer using Amicon Ultra-4 (10 kDa cut-off,
Millipore), the partially puriﬁed ND1 was stored at−80 °C until use.
Limited proteolysis was performed using lysylendopeptidase
(Lys-C, Wako Pure Chemicals, Osaka, Japan), endoprotease Asp-N
(Roche Applied Science, Penzberg, Germany), V8-protease (Roche), or
trypsin (Promega, Madison, WI) in 20 mM Tris/HCl buffer (pH 9.0,
containing 0.1% SDS), 50 mM phosphate buffer (pH 8.5, containing
0.01% SDS), 50 mM ammonium bicarbonate buffer (pH 7.8, containing
0.1% SDS), or ammonium bicarbonate buffer (pH 7.8, containing 0.01%
SDS), respectively. The digestionwas continued overnight at 37 °C. The
digests were further analyzed by tricine–SDS-PAGE (16.5% T/6% C)
[27].
2.5. Sequence analysis and topology prediction of the ND1 subunit
The number of transmembrane helices and membrane topology of
the bovine ND1 subunit (SwissProt accession number: P03887) were
predictedusingTMHMM(http://www.cbs.dtu.dk/services/TMHMM/),
TopPred (http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html)
and TMpred (http://www.ch.embnet.org/software/TMPRED_form.
html), and all the programs suggested eight transmembrane helices
with the N- and C-terminal regions facing outside the membrane
(intermembrane space). The ﬁnal membrane topology model accom-
modated an experimentally established model of the Rhodobacter
capsulatusNuoH [28], which is a bacterial homologue of the bovineND1.
For the analysis of the [125I]TDA cross-linking site in the ND1, the
mobility shifts of enzymatic digests on tricine gel were comparedwith
theoretical digests of the published protein sequences of bovine ND1
(P03887) using PeptideMass (http://expasy.org/tools/peptide-mass.
html) and Peptide Cutter (http://expasy.org/tools/peptidecutter/).
3. Results
3.1. Analysis of cross-linked region of [125I]TDA in the ND1 subunit
The interfacial region of the peripheral andmembrane armsmay be
“hot spot” for energy conversion in complex I and, consequently, for
inhibitor binding. The ND1 subunit contains putative eight transmem-
brane helices that construct the membrane arm [28]. This subunit is
believed to serve as a connector between the two arms [29].
Nevertheless, the very hydrophobic nature of the ND1 subunit has
hampered detailed characterization by 2D electrophoresis and mass
spectroscopy [21,22]. We speculate that acetogenins inhibit complex I
activity by disturbing the interaction between the peripheral and
membrane arms. To deepen our knowledge about the inhibition
mechanism of acetogenins, locating the region cross-linked by [125I]
TDA in the ND1 subunit is critical.
To this end, we tried to analyze the [125I]TDA-labeled ND1 subunit
by limited proteolysis using lysylendopeptidase (Lys-C), endoprotease
Asp-N, trypsin, or V8-protease. The [125I]TDA-labeled ND1 was
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followed by electroelution. Initially, we tried to recover the [125I]TDA-
labeled ND1 by acetone-precipitation from the elution buffer;
however, the resulting precipitate was highly hydrophobic and
insoluble in a digestion buffer even in the presence of 4 M urea or
0.1% SDS. In order to avoid protein aggregation, we prepared the
samples for enzymatic digestion by repeated concentration and buffer
exchange using centrifugal ﬁlter devices. For every protease treat-
ment, the SDS concentration in the digestion buffer was critical for
effective and complete digestion. When the enzymatic digestion was
carried out in the absence of SDS, it was always incomplete. The
optimal SDS concentrations for each protease treatment were
0.01–0.1% (w/v), as described in the Materials and methods.
The ND1 subunit has seven Lys and three Asp residues, which are
in principle cleaved by treatment with Lys-C and Asp-N, respectively.
When the labeled ND1 subunit was digested with Lys-C and Asp-N,
major radioactive bands migrated to ∼15 kDa and ∼17 kDa,
respectively (Fig. 2A). Considering the theoretical cleavage sites, the
Lys-C digest is predicted to be the peptide Tyr127–Glu262 (15.2 kDa)
which covers the 4th to 7th transmembrane helices (Fig. 2B). The
Asp-N digest is predicted to be Asp51–Phe198 (16.3 kDa) covering the
2nd to 5th transmembrane helices (Fig. 2B). Thus the cross-linked site
appeared to be in the region Tyr127–Phe198.
The results of digestion by these two enzymeswouldmake it easier
to trace smaller digests of the ND1 subunit obtained with trypsin or
V8-protease treatment. Digestion of the [125I]TDA-labeled ND1 by
trypsin revealed the migration of a radioactive band with an apparent
molecular mass of ∼7 kDa (Fig. 3A), suggesting the sequence Ala135–
Arg195 (6.8 kDa, Fig. 3B). On the other hand, V8-protease treatment
gave a radioactive band at ∼6 kDa (Fig. 3A), which is predicted to be
the peptide Val144–Glu192 (5.5 kDa, Fig. 3B). All together, the cross-
linked site of [125I]TDA must be within the sequence region Val144–
Glu192 (49 amino acids), which covers the 4th to 5th transmembrane
helices in the ND1 subunit (Fig. 4). V8-protease treatment was
carried out under various experimental conditions, but the fragmentsFig. 2. Proteolytic analysis of the ND1 subunit cross-linked by [125I]TDA. (A) The [125I]TD
electroelution. The isolated ND1 was digested by lysylendopeptidase (Lys-C) or endoprotease
sample buffer, and tricine–SDS-PAGE (16.5% T/6% C) was conducted. The amounts of added p
three independent measurements. (B) A schematic presentation of the limited proteolysis of
the ND1 subunit (P03887) in bovine complex I.which were cleaved at Glu170 in the loop region (Fig. 3B) were not
detected.
3.2. Competition with short-chain ubiquinones
A variety of inhibitors act at the terminal electron transfer step of
complex I [13–16]. These inhibitors are generally believed to bind to
the ubiquinone reduction site, but there is still no strong experimental
evidence to verify this [1]. Rather, competition experiments in earlier
photoafﬁnity labeling studies using photoreactive inhibitors [30,31] or
ubiquinones [32,33] suggested that the binding site of inhibitors is not
the same as that of ubiquinone. It is however realized that competition
experiments between strong inhibitors and exogenous short-chain
ubiquinones would be difﬁcult since the binding afﬁnity of the two
ligands differs toomuch (about three orders ofmagnitude) to examine
efﬁcient competitive behavior in a limited concentration range.
Therefore, the question of whether the binding sites for ubiquinone
and different inhibitors are identical remains to be answered.
As [125I]TDA turned out to be a prominent photoafﬁnity probe, we
tried to examine the competition by determining the suppressive
effect of exogenous short-chain ubiquinones on the cross-linking to
the ND1 subunit. First we used Q2 whose electron-accepting ability
from bovine complex I in terms of kcat/Km is the most efﬁcient among
related short-chain ubiquinones [34]. Interestingly, Q2 suppressed the
cross-linking in a concentration-dependent way (Fig. 5), especially at
30 μM (10,000-fold) and 60 μM (20,000-fold). Complete suppression
was not observed in the concentration range studied because of
largely different binding afﬁnities of TDA and Q2. The use of higher
concentrations of Q2 than that examined in Fig. 5 was impractical
because of the solubility limit.
We also carried out the competition test using a photoreactive
2-azido-Q2 (Fig. 1), which is able to cross-link to protein by UV-
irradiation, as demonstrated with the cytochrome bd complex from
Escherichia coli [35]. This bulky quinone serves as an efﬁcient
substrate of bovine complex I since the ubiquinone reduction site ofA-labeled ND1 was partially puriﬁed from SMP by Laemmli's SDS-PAGE, followed by
Asp-N (Asp-N) overnight at 37 °C. The digestions were quenched by the addition of 4×
roteases are shown at the top of each autoradiogram. Data shown are representative of
the ND1 subunit with Lys-C or Asp-N. Residue numbers refer to the mature sequence of
Fig. 3. Proteolytic analysis of the ND1 subunit cross-linked by [125I]TDA using trypsin or V8-protease (V8). (A) The [125I]TDA-labeled ND1was digested by trypsin or V8, and subjected
to tricine–SDS-PAGE (16.5% T/6% C). The amounts of added proteases are shown at the top of each autoradiogram. Data shown are representative of three independentmeasurements.
(B) A schematic presentation of the limited proteolysis of the ND1 subunit with trypsin or V8. The common region of the Lys-C and Asp-N digests (Tyr127–Phe198, 72 amino acids) is
also shown. Transmembrane heliceswere predicted by TMpred (http://www.ch.embnet.org/software/TMPRED_form.html) and TMHMM(http://www.cbs.dtu.dk/services/TMHMM/),
and presented as solid and dotted rectangles, respectively.
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forms of quinones [34,36]. The Km and Vmax values of 2-azido-Q2 with
complex I in SMP are 4.3 μM and 0.26 μmol/min/mg of protein,Fig. 4. Schematic representation of the membrane topology of the bovine ND1 subunit.
The membrane topology prediction was made based on computer programs and an
established model of R. capsulatus NuoH [28], as described in the Materials and
methods. The [125I]TDA-labeled region (Val144–Glu192, 49 amino acids) which covers
the 4th to 5th transmembrane helices is shown in dark gray. The locations of
representative sites of cleavage by the proteases are also indicated.respectively [23], being almost comparable to those of Q2. 2-Azido-Q2
suppressed the cross-linking slightly more efﬁciently than Q2. This is
probably because 2-azido-Q2 is capable of covalently binding to the
enzyme, though the yield of photo-cross-linking is low. Together
these results are the ﬁrst direct experimental evidence that an
inhibitor (an acetogenin derivative) and ubiquinone competitively
bind to the enzyme.Fig. 5. Effects of short-chain ubiquinones on the speciﬁc labeling of the ND1 subunit.
Bovine SMP (0.3 mg of protein/mL) were photo-cross-linked by [125I]TDA (3 nM) in the
presence of 2-azido-Q2 (closed circles) and Q2 (open circles) at given concentrations
(3–60 μM). The treated SMP were subjected to Laemmli's SDS-PAGE on a 12.5% gel, and
the residual radioactivity in the ND1 was quantiﬁed. Points represent means of three
independent measurements±standard deviation.
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Structure–activity studies on a series of acetogenins with bovine
complex I [37–39] strongly suggested that the polar hydroxylated bis-
tetrahydrofuran (THF)moiety resides at themembrane surface area in
the enzyme; in contrast, the γ-lactone buries into the hydrophobic
environment of the enzyme with the support of the hydrophobic and
ﬂexible alkyl spacer. The bis-THF and the γ-lactone moieties may be
located within a distance shorter than that of the 13-carbon extended
methylene chain [39]. Taking these ﬁndings into consideration, it is
reasonable to consider that the amino acid cross-linked by the
phenyldiazirine ring of [125I]TDA (i.e., a mimic of the γ-lactone ring)
resides in the hydrophobic 4th or 5th transmembrane helix, not in the
hydrophilic loop region connecting the two helices (Fig. 4).
We tried to identify the speciﬁc amino acid residue(s) cross-linked
by [125I]TDA by MALDI-TOF MS of tryptic digests of the ND1 subunit.
However the sequence coverage was low (15%) and the region
covering the 4th to 5th transmembrane helices was not detected.
Similar results were reported in previous mass spectrometric studies
of the ND1 subunit [21,31]. This may be primarily due to high
hydrophobicity of the subunit [21].
Heinrich and Werner [32] showed that a photoreactive ubiqui-
none, which possesses a photolabile group in the alkyl side chain,
binds to the 9.5 kDa subunit in Neurospora crassa complex I (B9
subunit in bovine). Yu et al. [33] revealed that a photoreactive
ubiquinone, which has a photolabile group in the quinone ring, binds
to the NuoM subunit in E. coli (ND4 subunit in bovine). In both studies,
the binding of photoreactive ubiquinones was not suppressed by an
excess amount of complex I inhibitors. Moreover, competition
experiments in earlier photoafﬁnity labeling studies using photo-
reactive inhibitors suggested that the binding site of inhibitors is not
the same as that of ubiquinone [30,31]. On the other hand, from
mutagenesis studies of yeast Yarrowia lipolytica complex I, Brandt
et al. indicated that although the mutations that exhibit inhibitor
(quinazoline and rotenone) resistance and lower ubiquinone reduc-
tase activity tend to be comparable, speciﬁc binding sites for
ubiquinone and different inhibitors are not identical [40,41]. Thus it
has remained to be solved whether the binding sites for ubiquinone
and different inhibitors are identical. Studies employing a Michaelis–
Menten type kinetic analysis of the data on NADH-exogenous quinone
oxidoreductase activity [13,14,42–44] would not solve this issue
because the physicochemical properties of the ubiquinones, the
inhibitors and the membrane-bound enzyme as well as the complex-
ity of the underlying catalytic mechanism make interpretation of the
kinetic data difﬁcult and ambiguous [15].
The present study has provided, for the ﬁrst time, direct
experimental evidence that an inhibitor (an acetogenin derivative)
and ubiquinone competitively bind to the enzyme. This is in contrast
to previous photoafﬁnity labeling studies demonstrating that the
binding of pyridaben to the PSST and ND1 subunits [30] and
quinazoline to the 49 kDa and ND1 subunits [31] is not suppressed
by an excess amount of short-chain ubiquinones. The ubiquinone
binding site in complex I may reside in the large pocket around iron–
sulfur cluster N2 which is formed by domains of the 49 kDa and PSST
subunits [11,40,41,45]. Several lines of evidence strongly suggest that
the ND1 subunit is one of the subunits constructing this large pocket
[17,29–31]. All together, themost straightforward interpretation of the
contradictory results obtained in competition tests is that the extent of
overlapping between different inhibitors and ubiquinone differs
depending upon the structural nature of the inhibitors. It is not
strange to consider that the precise manner in which chemically
diverse inhibitors bind differs due to remarkably different structural
properties. We therefore propose that not all inhibitors acting at the
terminal electron transfer step of complex I necessarily bind to the
ubiquinone binding site itself. Recently, we showed that the inhibition
site (or manner) of new types of inhibitors Δlac-acetogenins [17,46,47]and piperazines [48] is signiﬁcantly different from that of traditional
inhibitors. The occurrence of such unique inhibitors may be an
extreme example of the diversity of action manners of complex I
inhibitors.
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